Primary hepatocyte cultures for pharmaco-toxicological studies: at the busy crossroad of various anti-dedifferentiation strategies
The DOI matches its Crossref record; 423 of the 423 references it cites were found in a registry or an index.
Abstract
Continuously increasing understanding of the molecular triggers responsible for the onset of diseases, paralleled by an equally dynamic evolution of chemical synthesis and screening methods, offers an abundance of pharmacological agents with a potential to become new successful drugs. However, before patients can benefit of newly developed pharmaceuticals, stringent safety filters need to be applied to weed out unfavourable drug candidates. Cost effectiveness and the need to identify compound liabilities, without exposing humans to unnecessary risks, has stimulated the shift of the safety studies to the earliest stages of drug discovery and development. In this regard, in vivo relevant organotypic in vitro models have high potential to revolutionize the preclinical safety testing. They can enable automation of the process, to match the requirements of high-throughput screening approaches, while satisfying ethical considerations. Cultures of primary hepatocytes became already an inherent part of the preclinical pharmaco-toxicological testing battery, yet their routine use, particularly for long-term assays, is limited by the progressive deterioration of liver-specific features. The availability of suitable hepatic and other organ-specific in vitro models is, however, of paramount importance in the light of changing European legal regulations in the field of chemical compounds of different origin, which gradually restrict the use of animal studies for safety assessment, as curr…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased albumin secretion from spheroids compared to cell monolayers, as seen here, is consistent with observations reported in literature, which indicates that culturing the cells as spheroids may enhance homotypic cell-cell interactions within aggregated hepatocytes and improve functional outcomes of the hepatic construct [25,48].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [48]
In the citing paper
“Increased albumin secretion from spheroids compared to cell monolayers, as seen here, is consistent with observations reported in literature, which indicates that culturing the cells as spheroids may enhance homotypic cell-cell interactions within aggregated hepatocytes and improve functional outcomes of the hepatic construct [25,48].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [48]
In the citing paper
“Although scarcely distributed, the ECM is an integral part of the complex liver architecture and the restoration of cell-ECM contacts is crucial for the preservation of the differentiated hepatic phenotype in cell culture (Fraczek et al., 2013[12]; Ye et al., 2019[48]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Fraczek et al., 2013[12]
In the citing paper
“The application of primary human hepatocytes following isolation from human tissue is well accepted to be compromised by the process of dedifferentiation.”
From Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile (2017) · cites this paper as Fraczek et al. 2013
In the citing paper
“HNF1α, C/EBP and HNF1β were amongst the most significantly associated regulators with the loss of metabolic competence.”
From Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile (2017) · cites this paper as Fraczek et al. 2013
Citations
Cites
1 retracted
Datta, J., Kutay, H., Nasser, M. W., Nuovo, G. J., Wang, B., Majumder, S., Liu, C.-G., Volinia, S., Croce, C. M., Schmittgen, T. D., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6655 · Cited by 438
RetractedTakahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679 · cited 2×
“Besides altering the physical properties of chromatin, addition or removal of acetyl groups also modifies the array of posttranslational modifications of amino acids in the histones’ tails, which is believed to create a specific code, designated as the ‘histone code’ (Strahl and Allis 2000).”
BackgroundOkano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143
Chapter 4 Preparation of Isolated Rat Liver Cells
Seglen, P. O. (1976) · Methods in Cell Biology · doi:10.1016/s0091-679x(08)61797-5 · Cited by 5,310 · cited 2×
“Further detachment of cells from the extracellular matrix (ECM) backbone is achieved in a second step by perfusion with a collagenase solution (Seglen 1976; Papeleu et al. 2006a).”
BackgroundMethodThe Principles of Humane Experimental Technique
(1960) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1960.tb73127.x · Cited by 4,912
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807 · cited 1×
“000 lives are annually lost because of ADRs, while medical costs of treating their consequences translate into billions of dollars (Lazarou et al. 1998).”
BackgroundHIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLS
Berry, M. N., & Friend, D. S. (1969) · The Journal of Cell Biology · doi:10.1083/jcb.43.3.506 · Cited by 4,424
The price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167 · cited 4×
“Indeed, in the early 90s, unsatisfactory efficacy and pharmacokinetics were identified as the most prominent causes of drug attrition (Kola and Landis 2004; Schuster et al. 2005).”
BackgroundInfluential
Research works printed but not linked: 1
- Nishimura M, Ejiri Y, Kishimoto S, Suzuki S, Satoh T, Horie T, Narimatsu S, Naito S (2011) Expression levels of drug-metabolizing enzyme, transporter, and nuclear receptor mRNAs in a novel three-dimensional culture system for human hepatocytes using micro-space plates. Drug Metab Pharmacokinet 26(2):137–144 · DOI
Cited by
McGill, M. R., & Jaeschke, H. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1007-6 · Cited by 704
“Phenobarbital), can be added to the culture medium (171,174,175).”
A liver-on-a-chip platform with bioprinted hepatic spheroids
Bhise, N. S., Manoharan, V., Massa, S., Tamayol, A., Ghaderi, M., Miscuglio, M., Lang, Q., Shrike Zhang, Y., Shin, S. R., Calzone, G., et al. (2016) · Biofabrication · doi:10.1088/1758-5090/8/1/014101 · Cited by 615
Maturation of Induced Pluripotent Stem Cell Derived Hepatocytes by 3D-Culture
Gieseck III, R. L., Hannan, N. R. F., Bort, R., Hanley, N. A., Drake, R. A. L., Cameron, G. W. W., Wynn, T. A., & Vallier, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086372 · Cited by 197
“This is suggestive of contact-dependent apoptosis similar to that seen in low density PHH dedifferentiation [1,2].”
Engineering a perfusable 3D human liver platform from iPS cells
Schepers, A., Li, C., Chhabra, A., Seney, B. T., & Bhatia, S. (2016) · Lab on a Chip · doi:10.1039/c6lc00598e · Cited by 176
Heslop, J. A., Rowe, C., Walsh, J., Sison-Young, R., Jenkins, R., Kamalian, L., Kia, R., Hay, D., Jones, R. P., Malik, H. Z., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1694-y · Cited by 141
“Furthermore, following isolation, primary human hepatocytes undergo a rapid dedifferentiation process in which many unique hepatocyte characteristics are lost, reducing the physiological relevance of the model (Fraczek et al. 2013; Godoy et al. 2013).”
BackgroundInfluential
Metadata
- Authors
- Fraczek, J., Bolleyn, J., Vanhaecke, T., Rogiers, V., & Vinken, M.
- Affiliations
- Vrije Universiteit Brussel (BE)
- Corresponding author
- Fraczek, J.
- Venue
- Archives of Toxicology
- Published
- 2012-12-15
- Volume
- 87
- Issue
- 4
- Pages
- 577-610
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- OpenAlex
- W2018187848
- Cited by
- 119
- References
- 422
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 5 · 2023: 9 · 2022: 10 · 2021: 11 · 2020: 6 · 2019: 13 · 2018: 10 · 2017: 7 · 2016: 12 · 2015: 9 · 2014: 14 · 2013: 5
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Archives of Toxicology (publishedVersion)
- PubMed (publishedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- primary hepatocyte culture, hepatocyte dedifferentiation, preclinical safety, drug toxicity, high-throughput screening, alternatives to animal testing, long-term hepatocyte culture
- MeSH terms
- Animals, Animal Testing Alternatives, Cells, Cultured, Drug Evaluation, Preclinical, Humans, Xenobiotics, Apoptosis, Hepatocytes, Mice, Rats, Cell Dedifferentiation, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Primary hepatocyte cultures for pharmaco-toxicological studies: at the busy crossroad of various anti-dedifferentiation strategies. https://app.cochat.ai/papers/10.1007/s00204-012-0983-3
- The paper
- Fraczek, J., Bolleyn, J., Vanhaecke, T., Rogiers, V., & Vinken, M. (2013). Primary hepatocyte cultures for pharmaco-toxicological studies: at the busy crossroad of various anti-dedifferentiation strategies. Archives of Toxicology. https://doi.org/10.1007/s00204-012-0983-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.